Status:
COMPLETED
A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee
Lead Sponsor:
IDEA AG
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving ...
Detailed Description
This is a double-blind, active-controlled study of the safety of IDEA-033 in comparison to oral naproxen for the treatment of the signs and symptoms of osteoarthritis of the knee in patients who have ...
Eligibility Criteria
Inclusion
- Patients who completed Study 17-007 or discontinued from Study 17-007 due to lack of efficacy
- Patients who did not complete or discontinue from Study 17-007 must have osteoarthritis of both knees for a minimum of six months
- Have moderate pain in the most involved knee when not taking non-steroidal anti-inflammatory drugs (NSAIDs)
- Must have used an oral NSAID on at least three days per week for the last three months, or 25 of the 30 days before screening
- Demonstrate x-ray evidence of osteoarthritis in the most involved knee during the last six months
Exclusion
- Any patient currently receiving physical therapy to either knee or having a history of allergy, hypersensitivity or contraindication to ketoprofen, naproxen, or acetaminophen, an NSAID idiosyncrasy, or any other medical condition that would compromise the ability of the subject to complete the required assessments and visits
- For patients who did not participate in Study 17-007: having Grade 1 or Grade 4 severity of the most involved knee based on x-ray criteria
- Received intra-articular injections or arthroscopy of the most involved knee during three months before screening visit
- Have a large bulging effusion, or have inflammation of the most involved knee that could be related to gout, pseudogout-induced synovitis, or infection
- Have a history of partial or total knee replacement in either knee, or have a history of gout, pseudo-gout induced synovitis, or infection of the more severe knee
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT00265304
Start Date
July 1 2005
Last Update
March 20 2009
Active Locations (93)
Enter a location and click search to find clinical trials sorted by distance.
1
Capstone Clinical Trials Inc
Birmingham, Alabama, United States, 35209
2
Montgomery, Alabama, United States, 36101
3
Montgomery, Alabama, United States, 36124
4
Northport, Alabama, United States, 35476